Physician profile
Peter Schreiber
NPI 1306809769
$339.44
in general payments reported to CMS, 2019-2025
8 companies · $99.07 in 2025
The $99.07 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.57 · 2020: $88.64 · 2021: $38.63 · 2022: $39.54 · 2023: $22.99 · 2025: $99.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $99.07 | 2025 | Intracept |
| Pfizer INC. | $70.19 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $50.31 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $47.39 | 2022-2023 | Belbuca |
| Arbor Pharmaceuticals, INC. | $29.60 | 2019-2021 | |
| Medtronic USA, INC. | $16.02 | 2020 | |
| Si-Bone, INC. | $15.14 | 2022 | |
| Redhill Biopharma INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Schreiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.